Atypical Acute Rejection After Hand Transplantation

Skin rejection after hand transplantation is characterized by a maculopapular erythematous rash that may be diffuse, patchy or focal, and distributed over forearms and dorsum of the hands. This ‘classical’ pattern of rejection usually spares the skin of the palm and does not affect the nails. Herein, we report the experience on four cases presenting with an ‘atypical’ pattern of rejection that is novel in involving the palmar skin and the nails. All patients were young and exposed to repetitive and persistent mechanical stress of the palm. Characteristic features of rejection included a desquamative rash associated with dry skin, red papules, scaling and lichenification localized to the palm. Skin lesions were associated with nail dystrophy, degeneration, deformation or loss. Histology of the skin and nail bed revealed a lymphocytic infiltrate with predominance of T cells (CD3+, CD4+ and CD8+), with small numbers of B cells (CD20+ and CD79a+) and a low number of Forkhead transcription factor 3 (FOXP3)‐positive cells in one patient. The lesions persisted over weeks to months, responded poorly to steroid treatment and were managed with antithymocyte globulin (ATG; Thymoglobulin, Genzyme, Cambridge, MA), alemtuzumab and/or intensified maintenance immunosuppression.

[1]  Frédéric Schuind,et al.  The International Registry on Hand and Composite Tissue Transplantation , 2010, Transplantation.

[2]  F. Schuind,et al.  Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. , 2007, Transplant immunology.

[3]  R. Margreiter,et al.  First Forearm Transplantation: Outcome at 3 Years , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  F Schuind,et al.  Hand Transplantation: The State-of-the-Art , 2007, The Journal of hand surgery, European volume.

[5]  K. Kabashima,et al.  Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin , 2006, Clinical and experimental immunology.

[6]  James T. Elder,et al.  The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients , 2006, Archives of Dermatological Research.

[7]  T. Starzl,et al.  Tolerance for organ recipients: A clash of paradigms , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  F. Schuind,et al.  The First Belgian Hand Transplantation—37 Month Term Results , 2006, Journal of hand surgery.

[9]  C. Bodemer,et al.  Onychopathie associée au sirolimus chez les transplantés rénaux , 2006 .

[10]  R. Margreiter,et al.  Status 5 Years after Bilateral Hand Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  C. Bodemer,et al.  [Sirolimus-induced onychopathy in renal transplant recipients]. , 2006, Annales de dermatologie et de venereologie.

[12]  F. Baldanti,et al.  Cytomegalovirus-Related Complications in Human Hand Transplantation , 2005, Transplantation.

[13]  Marco Lanzetta,et al.  Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. , 2005, European journal of dermatology : EJD.

[14]  R. Margreiter,et al.  Steroid‐ and ATG‐Resistant Rejection After Double Forearm Transplantation Responds to Campath‐1H , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  M. Haberal,et al.  Nail disorders in hemodialysis patients and renal transplant recipients: a case-control study. , 2004, Journal of the American Academy of Dermatology.

[16]  Jean Kanitakis,et al.  Clinicopathologic features of graft rejection of the first human hand allograft , 2003, Transplantation.

[17]  P. Nghiem,et al.  Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. , 2002, Journal of the American Academy of Dermatology.

[18]  D. Remick,et al.  Early Chemokine Cascades in Murine Cardiac Grafts Regulate T Cell Recruitment and Progression of Acute Allograft Rejection1 , 2001, The Journal of Immunology.

[19]  W P Cooney,et al.  Successful hand transplantation--one year follow-up. , 2001, The New England journal of medicine.

[20]  R. Rault,et al.  Mycophenolate-Associated Onycholysis , 2000, Annals of Internal Medicine.

[21]  H. Uchi,et al.  Cytokines and chemokines in the epidermis. , 2000, Journal of dermatological science.

[22]  S. Gruber,et al.  Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. , 2000, The New England journal of medicine.

[23]  A. Monaco Transplantation: the state of the art. , 1990, Transplantation proceedings.

[24]  J. Czernielewski,et al.  Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production. , 1986, Clinical and experimental immunology.

[25]  D. Barclay,et al.  One-year follow-up , 1975 .